Zobrazeno 1 - 10
of 29
pro vyhledávání: '"PS Hari"'
Autor:
Aruna Korlimarla, PS Hari, Jyoti Prabhu, Chanthirika Ragulan, Yatish Patil, VP Snijesh, Krisha Desai, Aju Mathews, Sandhya Appachu, Ravi B. Diwakar, BS Srinath, Alan Melcher, Maggie Cheang, Anguraj Sadanandam
Publikováno v:
Translational Oncology, Vol 27, Iss , Pp 101574- (2023)
Externí odkaz:
https://doaj.org/article/8af7d49800d6483188b46b69120e86c7
Autor:
Lan, Linxiang, Evan, Theodore, Li, Huafu, Hussain, Aasia, Ruiz, E. Josue, Zaw Thin, May, Ferreira, Rute M. M., Ps, Hari, Riising, Eva M., Zen, Yoh, Almagro, Jorge, Ng, Kevin W., Soro-Barrio, Pablo, Nelson, Jessica, Koifman, Gabriela, Carvalho, Joana, Nye, Emma L., He, Yulong, Zhang, Changhua, Sadanandam, Anguraj, Behrens, Axel
Publikováno v:
Nature; 20240101, Issue: Preprints p1-6, 6p
Autor:
Burns, Jessica, Wilding, Christopher P., Krasny, Lukas, Zhu, Xixuan, Chadha, Madhumeeta, Tam, Yuen Bun, PS, Hari, Mahalingam, Aswanth H., Lee, Alexander T. J., Arthur, Amani, Guljar, Nafia, Perkins, Emma, Pankova, Valeriya, Jenks, Andrew, Djabatey, Vanessa, Szecsei, Cornelia, McCarthy, Frank, Ragulan, Chanthirika, Milighetti, Martina, Roumeliotis, Theodoros I.
Publikováno v:
Nature Communications; 6/29/2023, Vol. 14 Issue 1, p1-17, 17p
Autor:
Aruna Korlimarla, PS Hari, Jyoti Prabhu, Chanthirika Ragulan, Yatish Patil, VP Snijesh, Krisha Desai, Aju Mathews, Sandhya Appachu, Ravi B. Diwakar, BS Srinath, Maggie Cheang, Anguraj Sadanandam
BackgroundTriple-negative breast cancer (TNBC) is a heterogeneous disease with a significant clinical challenge. TNBC alarmingly comprises 25-30% of breast cancers in India compared with only 10-15% in the West. However, immunotherapy was approved fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41218f739a5fc7fe90eebb5dd0d0ac59
https://doi.org/10.1101/2022.03.06.483159
https://doi.org/10.1101/2022.03.06.483159
Autor:
Nwosu, Zeribe C., Ward, Matthew H., Sajjakulnukit, Peter, Poudel, Pawan, Ragulan, Chanthirika, Kasperek, Steven, Radyk, Megan, Sutton, Damien, Menjivar, Rosa E., Andren, Anthony, Apiz-Saab, Juan J., Tolstyka, Zachary, Brown, Kristee, Lee, Ho-Joon, Dzierozynski, Lindsey N., He, Xi, PS, Hari, Ugras, Julia, Nyamundanda, Gift, Zhang, Li, Halbrook, Christopher J., Carpenter, Eileen S., Shi, Jiaqi, Shriver, Leah P., Patti, Gary J., Muir, Alexander, Pasca di Magliano, Marina, Sadanandam, Anguraj, Lyssiotis, Costas A.
Publikováno v:
Nature; June 2023, Vol. 618 Issue: 7963 p151-158, 8p
Autor:
Lan, Linxiang, Evan, Theodore, Li, Huafu, Hussain, Aasia, Ruiz, E. Josue, Zaw Thin, May, Ferreira, Rute M. M., Ps, Hari, Riising, Eva M., Zen, Yoh, Almagro, Jorge, Ng, Kevin W., Soro-Barrio, Pablo, Nelson, Jessica, Koifman, Gabriela, Carvalho, Joana, Nye, Emma L., He, Yulong, Zhang, Changhua, Sadanandam, Anguraj
Publikováno v:
Nature; Jul2022, Vol. 607 Issue 7917, p163-168, 6p
Autor:
Panigrahi, Stuti, Pardeshi, Varsha Chhotusing, Chandrasekaran, Karthikeyan, Neelakandan, Karthik, PS, Hari, Vasudevan, Anil
Publikováno v:
Clinical and Experimental Pediatrics
Clinical and Experimental Pediatrics, Vol 64, Iss 7, Pp 355-363 (2021)
Clinical and Experimental Pediatrics, Vol 64, Iss 7, Pp 355-363 (2021)
Background Nephrotic syndrome (NS) is a common renal disorder in children attributed to podocyte injury. However, children with the same diagnosis have markedly variable treatment responses, clinical courses, and outcomes, suggesting molecular hetero
Autor:
PS Hari, Vincent Dp
Publikováno v:
Journal of Case Reports. 3:89-91
Autor:
Korlimarla, Aruna, PS, Hari, Prabhu, Jyoti, Ragulan, Chanthirika, Patil, Yatish, VP, Snijesh, Desai, Krisha, Mathews, Aju, Appachu, Sandhya, Diwakar, Ravi B., BS, Srinath, Melcher, Alan, Cheang, Maggie, Sadanandam, Anguraj
Publikováno v:
Translational Oncology; November 2022, Vol. 25 Issue: 1
Autor:
Tam YB; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Low K; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Ps H; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Chadha M; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Burns J; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Wilding CP; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Arthur A; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Chen TW; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan., Thway K; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Sadanandam A; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Jones RL; The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Huang PH; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom. paul.huang@icr.ac.uk.
Publikováno v:
Communications medicine [Commun Med (Lond)] 2024 May 18; Vol. 4 (1), pp. 93. Date of Electronic Publication: 2024 May 18.